Zuo, Mingrong
Zhang, Shuxin
Chen, Siliang
He, Yuze
Li, Junhong
Xiang, Yufan
Yuan, Yunbo
Li, Tengfei
Yang, Wanchun
Wang, Zhihao
Li, Wenhao
Chen, Ni
Yang, Yuan
Zeng, Yunhui
Mao, Qing
Chen, Mina https://orcid.org/0000-0002-7446-3978
Liu, Yanhui https://orcid.org/0000-0002-3722-3334
Funding for this research was provided by:
Sichuan Science and Technology Program grant
Sichuan Provincial Foundation of Science and Technology gran
National Natural Science Foundation of China (82403965, 82372836)
Sichuan Science and Technology Program gran
Sichuan Science and Technology Program gran
Article History
Received: 17 March 2025
Revised: 16 September 2025
Accepted: 6 October 2025
First Online: 24 October 2025
Competing interests
: MZ and YL hold an authorized Chinese invention patent relating to the method of the primary CAFs culturing (ZL202111097340.7). Other authors reported no conflict of interest.
: All procedures were performed in accordance with the ethical standards as outlined in the 1964 Declaration of Helsinki and its subsequent amendments, or with comparable ethical standards. All human tissues utilized in the present study were approved by the Ethics Committee on Biomedical Research, West China Hospital of Sichuan University (No.2021.1319), and attained written informed consent from patients or their legal guardians. All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of West China Hospital, Sichuan University, in compliance with the Guide for the Care and Use of Laboratory Animals.